Compliance with Intravesical BCG Therapy for Non-Muscle Invasive Bladder Cancer [0.03%]
膀胱癌-卡介苗治疗依从性下降
Timothy F Carroll,Joseph P Bardot,Justin David et al.
Timothy F Carroll et al.
Purpose: To evaluate demographic and clinical factors associated with non-compliance with intravesical Bacillus Calmette-Guérin (BCG) therapy in patients with non-muscle invasive bladder cancer (NMIBC). ...
Reply by Authors [0.03%]
作者回复
Jonathan J Song,James McAndrew Jones rd,David S Wang et al.
Jonathan J Song et al.
First-Line Anti-PD-1 Immunotherapy with Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: A Meta-Analysis by PD-1 Subtype [0.03%]
抗PD-1联合酪氨酸激酶抑制剂作为一线治疗转移性肾细胞癌的免疫疗法：按PD-1亚型进行的Meta分析
Wala Ben Kridis,Afef Khanfir
Wala Ben Kridis
Background: Immune checkpoint inhibitors targeting programmed death-1 (PD-1) in combination with tyrosine kinase inhibitors (TKIs) have reshaped the first-line treatment landscape of advanced renal cell carcinoma (RCC). H...
Editorial Commentary [0.03%]
述评
Matthew S Lee,Bodo E Knudsen,Michael Sourial
Matthew S Lee
Reply by Authors [0.03%]
作者回复
Michael W Bacchus,Shawn Dason
Michael W Bacchus
Utilization of Pre-Diagnostic Prostate MRI Among Rural Americans: An Analysis of Medicare Claims for Elevated PSA [0.03%]
美国农村地区 Medicare 数据中前列腺 MRI 在高 PSA 水平患者中的应用分析
Nathaniel Fox Hansen,Hanna Zurl,Stephan M Korn et al.
Nathaniel Fox Hansen et al.
Introduction and objectives: MRI as an initial test for elevated PSA increases detection of clinically significant prostate cancer while reducing overdiagnosis. Despite its proven benefit, access to MRI in rural areas is ...
Perioperative Outcomes of Nephrectomy for Autosomal Dominant Polycystic Kidney Disease [0.03%]
autosomal显性多囊肾病的肾切除术围手术期结果
Michael Waseer Bacchus,Vivian Wong,Akshay Sood et al.
Michael Waseer Bacchus et al.
Introduction: Patients with autosomal dominant polycystic kidney disease (ADPKD) frequently require nephrectomy before renal transplant or for clinical symptoms. We encountered no population-based data on perioperative ou...
Editorial Commentary [0.03%]
述评
Ben Pockros,Miriam Hadj-Moussa
Ben Pockros
Reply by Authors [0.03%]
作者回复
Reza Lahiji,Viraj A Master
Reza Lahiji
Editorial Commentary [0.03%]
编者按
Taylor Goodstein
Taylor Goodstein